Clinical trial
Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who…
NCT00282984 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00282984 |
|---|---|
| Title | Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking |
| Official title | A 12-Week, Double-Blind, Placebo-Controlled, Multicenter Study With A 40 Week Follow Up Evaluating the Safety and Efficacy of Varenicline Tartrate 1 Milligram (Mg) Twice Daily (BID) for Smoking Cessation in Subjects With Cardiovascular Disease |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | placebo, Varenicline |
| Enrollment | 714 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | Jan 27, 2006 |
| Last update posted | Apr 5, 2017 |
| Countries | Argentina, Australia, Brazil, Canada, Czechia, Denmark, France, Germany, Greece, Mexico, Netherlands, South Korea and 3 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: